Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burnier

Showing results (131-140 of 284) with videos related to

Pageof 29
Sort By:
Clinical and Experimental Pharmacology & Physiology|December 15, 2010
Experience with angiotensin II antagonists in hypertensive patientsB Waeber, M Burnier, J Nussberger, et al.
Transplantation|August 13, 1998
Uricosuric effect of the angiotensin II receptor antagonist losartan in heart transplant recipientsG Minghelli, C Seydoux, J J Goy, et al.
Revue Medicale Suisse|February 8, 2011
[Managing hypertension: the uncertainty of definitions and targets]V Forni, G Wuerzner, M Pruijm, et al.
Ophthalmology|December 31, 1997
Clinically suspected primary acquired nasolacrimal duct obstruction: clinicopathologic review of 150 patientsN Tucker, D Chow, F Stockl, et al.
Revue Medicale Suisse|March 29, 2012
[Renal amyloidosis]P Cuchard, R Cuchard, S Rotman, et al.
The American Journal of Physiology|August 1, 1983
Blood pressure maintenance in awake dehydrated rats: renin, vasopressin, and sympathetic activityM Burnier, J Biollaz, D B Brunner, et al.
British Journal of Pharmacology|November 1, 1995
Effect of endotoxin on the angiotensin II receptor in cultured vascular smooth muscle cellsM Burnier, G Centeno, G Waeber, et al.
Revue Medicale Suisse|March 29, 2012
[What reasonable applications for regional citrate anticoagulation in renal replacement therapy?]S Kissling, P Wilson, C Ridel, et al.
Revue Medicale Suisse|October 8, 2009
[Hypertension in solid organ transplants]N Glatz, G Wuerzner, M Pruijm, et al.
Revue Medicale Suisse|April 23, 2015
[Renal aspects of sodium glucose cotransporter 2 inhibitors]F Beaud, M Pruijm, A Humbert, et al.
Pageof 29

Showing results (131-140 of 284) with videos related to

Sort By:
Pageof 29
Clinical and Experimental Pharmacology & Physiology|December 15, 2010
Experience with angiotensin II antagonists in hypertensive patientsB Waeber, M Burnier, J Nussberger, et al.
Transplantation|August 13, 1998
Uricosuric effect of the angiotensin II receptor antagonist losartan in heart transplant recipientsG Minghelli, C Seydoux, J J Goy, et al.
Revue Medicale Suisse|February 8, 2011
[Managing hypertension: the uncertainty of definitions and targets]V Forni, G Wuerzner, M Pruijm, et al.
Ophthalmology|December 31, 1997
Clinically suspected primary acquired nasolacrimal duct obstruction: clinicopathologic review of 150 patientsN Tucker, D Chow, F Stockl, et al.
Revue Medicale Suisse|March 29, 2012
[Renal amyloidosis]P Cuchard, R Cuchard, S Rotman, et al.
The American Journal of Physiology|August 1, 1983
Blood pressure maintenance in awake dehydrated rats: renin, vasopressin, and sympathetic activityM Burnier, J Biollaz, D B Brunner, et al.
British Journal of Pharmacology|November 1, 1995
Effect of endotoxin on the angiotensin II receptor in cultured vascular smooth muscle cellsM Burnier, G Centeno, G Waeber, et al.
Revue Medicale Suisse|March 29, 2012
[What reasonable applications for regional citrate anticoagulation in renal replacement therapy?]S Kissling, P Wilson, C Ridel, et al.
Revue Medicale Suisse|October 8, 2009
[Hypertension in solid organ transplants]N Glatz, G Wuerzner, M Pruijm, et al.
Revue Medicale Suisse|April 23, 2015
[Renal aspects of sodium glucose cotransporter 2 inhibitors]F Beaud, M Pruijm, A Humbert, et al.
Pageof 29